Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Apr;83(8):2699–2703. doi: 10.1073/pnas.83.8.2699

Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo.

D Aragnol, L D Leserman
PMCID: PMC323367  PMID: 3458229

Abstract

In a study designed to evaluate the potential for in vivo manipulation of the circulation and tissue distribution of injected liposomes, mice were passively injected with antidinitrophenyl (anti-DNP) monoclonal antibodies of the IgG2a or IgG2b subclasses or were immunized with the nitrophenyl hapten bound to a protein carrier. They were then injected i.v. with 125I- and carboxyfluorescein-labeled, DNP-bearing liposomes. Circulation time of the DNP-bearing liposomes was markedly reduced in actively and passively immune mice, with increased deposition of liposomes in the liver. The increased clearance of liposomes could be abrogated by injection of a monoclonal antibody directed against the murine IgG Fc receptor (2.4G2). The results suggest that clearance of ligand-bearing reagent in the face of an immune response may be modified by specific immunologic manipulation in vivo.

Full text

PDF
2699

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abra R. M., Bosworth M. E., Hunt C. A. Liposome disposition in vivo: effects of pre-dosing with lipsomes. Res Commun Chem Pathol Pharmacol. 1980 Aug;29(2):349–360. [PubMed] [Google Scholar]
  2. Allison A. G., Gregoriadis G. Liposomes as immunological adjuvants. Nature. 1974 Nov 15;252(5480):252–252. doi: 10.1038/252252a0. [DOI] [PubMed] [Google Scholar]
  3. Alving C. R. Natural antibodies against phospholipids and liposomes in humans. Biochem Soc Trans. 1984 Apr;12(2):342–344. doi: 10.1042/bst0120342. [DOI] [PubMed] [Google Scholar]
  4. Baldwin R. W., Pimm M. V. Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting. Cancer Metastasis Rev. 1983;2(1):89–106. doi: 10.1007/BF00046907. [DOI] [PubMed] [Google Scholar]
  5. Cawley D. B., Herschman H. R., Gilliland D. G., Collier R. J. Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic. Cell. 1980 Nov;22(2 Pt 2):563–570. doi: 10.1016/0092-8674(80)90366-9. [DOI] [PubMed] [Google Scholar]
  6. Czop J. K., Austen K. F. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis. Proc Natl Acad Sci U S A. 1985 May;82(9):2751–2755. doi: 10.1073/pnas.82.9.2751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ellens H., Mayhew E., Rustum Y. M. Reversible depression of the reticuloendothelial system by liposomes. Biochim Biophys Acta. 1982 Feb 25;714(3):479–485. doi: 10.1016/0304-4165(82)90157-x. [DOI] [PubMed] [Google Scholar]
  8. Fidler I. J., Sone S., Fogler W. E., Barnes Z. L. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1680–1684. doi: 10.1073/pnas.78.3.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  10. Geiger B., Gitler C., Calef E., Arnon R. Dynamics of antibody- and lectin-mediated endocytosis of hapten-containing liposomes by murine macrophages. Eur J Immunol. 1981 Sep;11(9):710–716. doi: 10.1002/eji.1830110908. [DOI] [PubMed] [Google Scholar]
  11. Hanspal M., Ralston G. B. Purification of a trypsin-insensitive fragment of spectrin from human erythrocyte membranes. Biochim Biophys Acta. 1981 Jul 28;669(2):133–139. doi: 10.1016/0005-2795(81)90234-8. [DOI] [PubMed] [Google Scholar]
  12. Heath T. D., Fraley R. T., Papahdjopoulos D. Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab')2 to vesicle surface. Science. 1980 Oct 31;210(4469):539–541. doi: 10.1126/science.7423203. [DOI] [PubMed] [Google Scholar]
  13. Huang A., Huang L., Kennel S. J. Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting. J Biol Chem. 1980 Sep 10;255(17):8015–8018. [PubMed] [Google Scholar]
  14. Jack R. M., Fearon D. T. Altered surface distribution of both C3b receptors and Fc receptors on neutrophils induced by anti-C3b receptor or aggregated IgG. J Immunol. 1984 Jun;132(6):3028–3033. [PubMed] [Google Scholar]
  15. Kao Y. J., Juliano R. L. Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles. Biochim Biophys Acta. 1981 Nov 5;677(3-4):453–461. doi: 10.1016/0304-4165(81)90259-2. [DOI] [PubMed] [Google Scholar]
  16. Kirby C., Clarke J., Gregoriadis G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J. 1980 Feb 15;186(2):591–598. doi: 10.1042/bj1860591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kurlander R. J., Ellison D. M., Hall J. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J Immunol. 1984 Aug;133(2):855–862. [PubMed] [Google Scholar]
  18. Leserman L. D., Barbet J., Kourilsky F., Weinstein J. N. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature. 1980 Dec 11;288(5791):602–604. doi: 10.1038/288602a0. [DOI] [PubMed] [Google Scholar]
  19. Leserman L. D., Weinstein J. N., Blumenthal R., Terry W. D. Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4089–4093. doi: 10.1073/pnas.77.7.4089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levy R., Miller R. A. Tumor therapy with monoclonal antibodies. Fed Proc. 1983 Jun;42(9):2650–2656. [PubMed] [Google Scholar]
  21. Lewis J. T., Hafeman D. G., McConnell H. M. Kinetics of antibody-dependent binding of haptenated phospholipid vesicles to a macrophage-related cell line. Biochemistry. 1980 Nov 11;19(23):5376–5386. doi: 10.1021/bi00564a036. [DOI] [PubMed] [Google Scholar]
  22. Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasi L., Mehta K., Fainstein V., Luna M., Hersh E. M., Juliano R. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis. 1983 May;147(5):939–945. doi: 10.1093/infdis/147.5.939. [DOI] [PubMed] [Google Scholar]
  23. Mauk M. R., Gamble R. C., Baldeschwieler J. D. Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4430–4434. doi: 10.1073/pnas.77.8.4430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mellman I. S., Plutner H., Steinman R. M., Unkeless J. C., Cohn Z. A. Internalization and degradation of macrophage Fc receptors during receptor-mediated phagocytosis. J Cell Biol. 1983 Mar;96(3):887–895. doi: 10.1083/jcb.96.3.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Paraskevas F., Lee S. T., Orr K. B., Israels L. G. A receptor for Fc on mouse B-lymphocytes. J Immunol. 1972 May;108(5):1319–1327. [PubMed] [Google Scholar]
  26. Patel K. R., Li M. P., Baldeschwieler J. D. Suppression of liver uptake of liposomes by dextran sulfate 500. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6518–6522. doi: 10.1073/pnas.80.21.6518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Petty H. R., Hafeman D. G., McConnell H. M. Specific antibody-dependent phagocytosis of lipid vesicles by RAW264 macrophages results in the loss of cell surface Fc but not C3b receptor activity. J Immunol. 1980 Dec;125(6):2391–2396. [PubMed] [Google Scholar]
  28. Rebaï N., Malissen B. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens. 1983 Aug;22(2):107–117. doi: 10.1111/j.1399-0039.1983.tb01176.x. [DOI] [PubMed] [Google Scholar]
  29. Reininger L., Fueri J., Boned A., Prat M., Landolfo S., Rubin B. On the molecular basis of T-helper-cell function. IV. B-lymphocyte-promotor factors: on their mode of action, biochemical nature and possible relationship to molecules involved in specific T-helper-cell activity. Cell Immunol. 1985 Apr 15;92(1):85–104. doi: 10.1016/0008-8749(85)90067-x. [DOI] [PubMed] [Google Scholar]
  30. Schroff R. W., Foon K. A., Beatty S. M., Oldham R. K., Morgan A. C., Jr Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985 Feb;45(2):879–885. [PubMed] [Google Scholar]
  31. Schroit A. J. Synthesis and properties of a nonexchangeable radioiodinated phospholipid. Biochemistry. 1982 Oct 12;21(21):5323–5328. doi: 10.1021/bi00264a031. [DOI] [PubMed] [Google Scholar]
  32. Segal D. M., Titus J. A. The subclass specificity for the binding of murine myeloma proteins to macrophage and lymphocyte cell lines and to normal spleen cells. J Immunol. 1978 Apr;120(4):1395–1403. [PubMed] [Google Scholar]
  33. Shawler D. L., Bartholomew R. M., Smith L. M., Dillman R. O. Human immune response to multiple injections of murine monoclonal IgG. J Immunol. 1985 Aug;135(2):1530–1535. [PubMed] [Google Scholar]
  34. Springer T. A., Unkeless J. C. Analysis of macrophage differentiation and function with monoclonal antibodies. Contemp Top Immunobiol. 1984;13:1–31. doi: 10.1007/978-1-4757-1445-6_1. [DOI] [PubMed] [Google Scholar]
  35. Teillaud J. L., Diamond B., Pollock R. R., Fajtova V., Scharff M. D. Fc receptors on cultured myeloma and hybridoma cells. J Immunol. 1985 Mar;134(3):1774–1779. [PubMed] [Google Scholar]
  36. Unkeless J. C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979 Sep 19;150(3):580–596. doi: 10.1084/jem.150.3.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vitetta E. S., Uhr J. W. The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulation. Transplantation. 1984 Jun;37(6):535–538. doi: 10.1097/00007890-198406000-00001. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES